Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq:APLS) today announced that the company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024, at 9:45 a.m. PT.
Related news for (APLS)
- Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results
- Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)